[1]
V. Ramteke, S. Dash, S. Bose, and R. Jain, “Denosumab For The Treatment Of Bisphosphonate-Refractory Hypercalcemia Of Malignancy - A Case Report”, jms, vol. 18, no. 2, pp. 153-155, Dec. 2015.